Michel Clanet

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Ludwig Kappos, Jan Hillert, Gilles Edan, 2007, The Lancet Neurology.

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.

Ludwig Kappos, Stefan Wagenpfeil, Martin Hardmeier, 2003, Archives of neurology.